Today at a glance: after closing today at $23.42, the US-German healthcare company peaked at $23.52 before giving up early gains and closing at $23.42.
Fresenius Medical Care's uptick comes amid good United States macroeconomic data released during the day — United States Average Hourly Earnings beat the 0.3% projections, with 0.5%. Data for United States Non Farm Payrolls published today at 12:30 UTC came out at 253,000, beating projections of 180,000 and showing improvement over the preceding figure of 165,000. Highly important Unemployment Rate data from United States beat analyst expectations of 3.6 with a reading of 3.4.
Fresenius Medical Care AG & Co. KGaA made an initial breakout above its 10 day Simple Moving Average at $23.46, a potential indicator of a newly emerging bullish phase. Despite this, Fresenius Medical Care could be slowing down soon as it approaches resistance at $23.36. Of course, crossing it might suggest further gains are ahead.
Examining the technical analysis landscape, Fresenius Medical Care might continue its downtrend in the short term.
A look at other health care stocks also showed bullish price action as Bristol-Myers Squibb Company was up 1.98%. Sanofi was up 1.9%. Amgen was up 2%.
The US-German healthcare company has managed to gain 43.7% so far this year despite trading at lows around $12.81 previously.